Brian Hanley is the founder and chief scientist for Butterfly Sciences. Brian holds a Microbiology PhD from UC Davis with honors completed in under three years. Brian guest lectured for the MBA program at Santa Clara University for 6 years and has years of operations experience in the USA and Central Asia in startups and early stage companies. He has publications in epidemiology, biotechnology, economics and a portfolio of patents in addition to chapters on biodefense and terrorism in DHS/West Point sponsored books. Since founding Butterfly Sciences, Brian has developed gene therapies for HIV treatment   and new approaches to flow-cytometry diagnostics.